TITLE

Letter: Co-trimoxazole resistance

AUTHOR(S)
Then, R; Angehrn, P
PUB. DATE
January 1974
SOURCE
British Medical Journal;1/12/1974, Vol. 1 Issue 5897, p78
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
64109350

 

Related Articles

  • Cotrimoxazole prophylaxis for infants exposed to HIV infection. Graham, Stephen M. // Bulletin of the World Health Organization;Apr2004, Vol. 82 Issue 4, p297 

    Focuses on the risks and benefits of implementing guidelines on the use of cotrimoxazole prophylaxis for prevention of HIV-related infections in infants in Africa. Toxicity of cotrimoxazole; Improvement of diagnosis for HIV infection; Reduction of the duration of prophylaxis and risk of...

  • Cotrimoxazole myelotoxicity in hematopoietic SCT recipients: time for reappraisal. Fontanet, A.; Chalandon, Y.; Roosnek, E.; Mohty, B.; Passweg, J. R. // Bone Marrow Transplantation;Sep2011, Vol. 46 Issue 9, p1272 

    A letter to the editor is presented which discusses cotrimoxazole myelotoxicity in recipients of hematopoietic stem cell transplantation (HSCT).

  • Susceptibility of Gra Negative Bacteria to Cotrimoxazole in Specimens Sent to the Laboratory of Shahidbeheshti Hospital. Sharif, Alireza; Sharif, Mohammad Reza; Alizargar, Javad // Middle East Journal of Scientific Research;2014, Vol. 21 Issue 3, p440 

    Antibiotic resistance represents a complex dynamics problem, results in increasing cost of treatment, morbidity and mortality. As the use of Cotrimoxazole increases in the treatment of Gram-negative infections, pattern of infection and bacterial susceptibility of Gram-negative bacteria to...

  • Refractory Craniofacial Actinomycetoma Due to Streptomyces somaliensis That Required Salvage Therapy with Amikacin and Imipenem. Baril, Laurence; Boiron, Patrick; Manceron, VĂ©ronique; Ely, Seydina Oumar Ould; Jamet, Pierre; Favre, Estelle; Caumes, Eric; Bricaire, Francois // Clinical Infectious Diseases;8/1/1999, Vol. 29 Issue 2, p460 

    Presents a case of mycetoma of the face and skull due to Streptomyces (S.) somaliensis resistant to co-trimoxazole clinically and in vitro. Initial therapy for craniofacial mycetoma; Resistance and susceptibility of S. somaliensis to several drugs; Cranial images of a patient with craniofacial...

  • Use of anitbiotics. Reeves, D.S.; Bint, A.J.; Bullock, D.W. // British Medical Journal;8/5/1978, Vol. 2 Issue 6134, p410 

    Examines the effectiveness of antibacterial agents sulphonamides, co-trimoxazole and tetracyclines. Differences between sulfonamide derivatives; Mode of action and resistance trimoxazole; Adverse reactions to tetracyclines.

  • Co-trimoxazole versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus bacteraemia: a retrospective cohort study. Goldberg, Elad; Paul, Mical; Talker, Olga; Samra, Zmira; Raskin, Maria; Hazzan, Rawi; Leibovici, Leonard; Bishara, Jihad // Journal of Antimicrobial Chemotherapy (JAC);Aug2010, Vol. 65 Issue 8, p1779 

    Objectives: To evaluate the efficacy and safety of co-trimoxazole versus that of vancomycin in adults with methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia.

  • Cotrimoxazole: Drug resistance: case report.  // Reactions Weekly;Jun2019, Vol. 1756 Issue 1, p118 

    A case study of a 40-year-old man is presented, who developed resistance following administration of cotrimoxazole for infection with Stenotrophomonasmaltophilia (SM).

  • Therapeutic Challenge for Isospora belli Enteritis in an AIDS Patient Who Developed Lyell Syndrome after Co-Trimoxazole Therapy. Romeu, Joan; Clotet, Bonaventura; Tural, Cristina; Carles, Joan; Foz, Marius // American Journal of Gastroenterology;Feb1989, Vol. 84 Issue 2, p207 

    Presents a letter to the editor about an AIDS patient with Isospora belli enteritis who developed a Lyell syndrome secondary to treatment with co-trimoxazole.

  • PCP Prophylaxis in Perinatally HIV-Exposed Infant. Shahid, Sukhbir Kaur // Indian Pediatrics;Nov2008, Vol. 45 Issue 11, p939 

    A letter to the editor is presented about the recommendations for cotrimoxazole Pneumocystis carinii pneumonia (PCP) prophylaxis in perinatally human immunodeficiency virus (HIV)-exposed babies.

  • PCP Prophylaxis in Perinatally HIV-Exposed Infant. Tullu, Milind S. // Indian Pediatrics;Nov2008, Vol. 45 Issue 11, p939 

    A response to a letter to the editor about the recommendations for cotrimoxazole Pneumocystis carinii pneumonia (PCP) prophylaxis in perinatally human immunodeficiency virus (HIV)-exposed babies is presented.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics